Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuralgia | 8 | 2023 | 13 | 4.780 |
Why?
|
| Nerve Regeneration | 11 | 2022 | 39 | 4.380 |
Why?
|
| Wound Healing | 6 | 2021 | 69 | 3.060 |
Why?
|
| Phantom Limb | 3 | 2023 | 3 | 2.220 |
Why?
|
| Axons | 7 | 2015 | 106 | 2.210 |
Why?
|
| Platelet-Rich Plasma | 5 | 2021 | 5 | 2.080 |
Why?
|
| Ganglia, Spinal | 7 | 2018 | 36 | 2.060 |
Why?
|
| Hyperbaric Oxygenation | 5 | 2015 | 33 | 1.740 |
Why?
|
| Recovery of Function | 4 | 2020 | 89 | 1.670 |
Why?
|
| Hypothermia, Induced | 5 | 2010 | 26 | 1.360 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 137 | 1.290 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 166 | 1.220 |
Why?
|
| Sensory Receptor Cells | 3 | 2020 | 31 | 1.200 |
Why?
|
| Pressure Ulcer | 2 | 2015 | 6 | 0.870 |
Why?
|
| Spinal Cord | 4 | 2018 | 85 | 0.830 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2010 | 342 | 0.760 |
Why?
|
| Sural Nerve | 2 | 2011 | 4 | 0.740 |
Why?
|
| Cytokines | 2 | 2019 | 569 | 0.700 |
Why?
|
| Humans | 32 | 2023 | 34853 | 0.690 |
Why?
|
| Animals | 18 | 2020 | 14307 | 0.660 |
Why?
|
| Inflammation | 3 | 2019 | 577 | 0.650 |
Why?
|
| Schwann Cells | 2 | 2009 | 13 | 0.640 |
Why?
|
| Spinal Cord Injuries | 2 | 2010 | 60 | 0.590 |
Why?
|
| Peripheral Nerves | 3 | 2022 | 14 | 0.580 |
Why?
|
| Regeneration | 1 | 2015 | 20 | 0.540 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 358 | 0.520 |
Why?
|
| Ischemia | 2 | 2006 | 45 | 0.510 |
Why?
|
| Chronic Disease | 2 | 2015 | 469 | 0.490 |
Why?
|
| Neurons | 4 | 2019 | 1130 | 0.460 |
Why?
|
| Electric Stimulation | 2 | 2015 | 177 | 0.450 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 3 | 0.440 |
Why?
|
| Pain | 1 | 2015 | 249 | 0.430 |
Why?
|
| Radiation Injuries | 1 | 2012 | 23 | 0.430 |
Why?
|
| Ulnar Neuropathies | 1 | 2011 | 1 | 0.430 |
Why?
|
| Embolism, Air | 1 | 2011 | 1 | 0.410 |
Why?
|
| Medical Errors | 1 | 2011 | 6 | 0.410 |
Why?
|
| Brain | 3 | 2019 | 1268 | 0.410 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 30 | 0.390 |
Why?
|
| Sciatic Neuropathy | 1 | 2010 | 1 | 0.380 |
Why?
|
| Growth Cones | 2 | 2009 | 12 | 0.380 |
Why?
|
| Sciatic Nerve | 1 | 2010 | 11 | 0.380 |
Why?
|
| Neurosurgical Procedures | 2 | 2007 | 25 | 0.370 |
Why?
|
| Heart Diseases | 1 | 2011 | 99 | 0.370 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2009 | 2 | 0.370 |
Why?
|
| Ultrasonography | 1 | 2010 | 115 | 0.360 |
Why?
|
| Neurites | 1 | 2009 | 35 | 0.360 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 66 | 0.350 |
Why?
|
| Tacrolimus | 1 | 2009 | 10 | 0.340 |
Why?
|
| Brain Injuries | 1 | 2010 | 104 | 0.330 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 72 | 0.330 |
Why?
|
| Brain Ischemia | 1 | 2010 | 179 | 0.320 |
Why?
|
| Radial Nerve | 1 | 2007 | 2 | 0.320 |
Why?
|
| Morphine | 1 | 2008 | 80 | 0.320 |
Why?
|
| Models, Animal | 3 | 2015 | 131 | 0.290 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 7 | 0.290 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2006 | 45 | 0.280 |
Why?
|
| Cell Communication | 1 | 2006 | 93 | 0.270 |
Why?
|
| Neuroprotective Agents | 2 | 2008 | 231 | 0.260 |
Why?
|
| Cell Membrane | 1 | 2006 | 360 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 28 | 0.240 |
Why?
|
| Extremities | 1 | 2023 | 17 | 0.230 |
Why?
|
| Bacterial Infections | 2 | 2015 | 44 | 0.230 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 70 | 0.230 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 195 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 89 | 0.220 |
Why?
|
| Rats | 5 | 2011 | 3261 | 0.220 |
Why?
|
| Asthma | 1 | 2006 | 363 | 0.210 |
Why?
|
| Adult | 5 | 2022 | 11034 | 0.180 |
Why?
|
| Nociceptors | 1 | 2019 | 31 | 0.180 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2018 | 4 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 11 | 0.160 |
Why?
|
| Analgesics | 1 | 2018 | 56 | 0.150 |
Why?
|
| Nerve Net | 1 | 2018 | 72 | 0.150 |
Why?
|
| Cell Death | 2 | 2010 | 260 | 0.140 |
Why?
|
| Ligaments | 1 | 2015 | 2 | 0.140 |
Why?
|
| Tendon Injuries | 1 | 2015 | 3 | 0.140 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 6 | 0.140 |
Why?
|
| Debridement | 1 | 2015 | 4 | 0.140 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2015 | 2 | 0.140 |
Why?
|
| Bandages | 1 | 2015 | 5 | 0.130 |
Why?
|
| Administration, Topical | 1 | 2015 | 39 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2015 | 31 | 0.130 |
Why?
|
| Male | 6 | 2011 | 18870 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2015 | 51 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 92 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 109 | 0.130 |
Why?
|
| Light | 1 | 2015 | 180 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 62 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 91 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 24 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2009 | 1442 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2015 | 252 | 0.120 |
Why?
|
| Calcium | 2 | 2009 | 445 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 1534 | 0.120 |
Why?
|
| United States | 1 | 2023 | 3894 | 0.120 |
Why?
|
| Time Factors | 2 | 2009 | 1681 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 355 | 0.110 |
Why?
|
| Stem Cells | 1 | 2013 | 132 | 0.110 |
Why?
|
| Young Adult | 1 | 2022 | 4012 | 0.110 |
Why?
|
| Fibrin | 1 | 2011 | 8 | 0.110 |
Why?
|
| Necrosis | 1 | 2012 | 45 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2015 | 366 | 0.110 |
Why?
|
| Subclavian Vein | 1 | 2011 | 2 | 0.100 |
Why?
|
| Vena Cava, Superior | 1 | 2011 | 4 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 48 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 26 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 27 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 260 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1349 | 0.100 |
Why?
|
| Collagen | 1 | 2011 | 162 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2011 | 161 | 0.100 |
Why?
|
| Wallerian Degeneration | 1 | 2010 | 1 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 968 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 15 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2009 | 96 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2009 | 186 | 0.090 |
Why?
|
| Immunophilins | 1 | 2009 | 5 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2006 | 874 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 424 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 841 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2009 | 209 | 0.080 |
Why?
|
| Remission Induction | 1 | 2008 | 18 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2009 | 123 | 0.080 |
Why?
|
| Immune System | 1 | 2008 | 40 | 0.080 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 50 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2008 | 32 | 0.080 |
Why?
|
| Microscopy | 1 | 2008 | 32 | 0.080 |
Why?
|
| Anura | 1 | 2008 | 29 | 0.080 |
Why?
|
| Middle Aged | 2 | 2011 | 9642 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2006 | 33 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1300 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 597 | 0.060 |
Why?
|
| Paraplegia | 1 | 2003 | 2 | 0.060 |
Why?
|
| Quadriplegia | 1 | 2003 | 4 | 0.060 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 26 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2003 | 52 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 65 | 0.060 |
Why?
|
| Capsaicin | 1 | 2003 | 23 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2003 | 56 | 0.060 |
Why?
|
| Mice | 1 | 2010 | 5668 | 0.040 |
Why?
|
| Adolescent | 1 | 2008 | 5035 | 0.040 |
Why?
|
| Disease Management | 1 | 2014 | 61 | 0.030 |
Why?
|
| Female | 1 | 2011 | 19873 | 0.030 |
Why?
|
| Child | 1 | 2014 | 2875 | 0.020 |
Why?
|
| Cell Line | 1 | 2003 | 1289 | 0.010 |
Why?
|